2″ oxo-voruscharin and derivatives thereof

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C540S061000

Reexamination Certificate

active

07320971

ABSTRACT:
2″ oxo-voruscharin compound and derivatives thereof are disclosed as well as pharmaceutical compositions which include 2″ oxo-voruscharin compound or derivatives thereof. The disclosed 2″ oxo-voruscharin compound and its derivatives are useful for cancer treatment. Methods of treating cancer using the disclosed compounds are also disclosed.

REFERENCES:
patent: 5645988 (1997-07-01), Vande Woude et al.
Desheesh et al., “Glycosidic cardenolides. I. Chemistry of isolation and purification from Calotropis procera plant.” Alexandria Science Exchange, vol. 21(3), pp. 221-228, 2000. Abstract only.
Cheung, et al. “Cardenolide Glycosides of the Asclepiadaceae. New Glycosides fromAsclepias fruticosaand the Stereochemistry of Uscharin, Voruscharin and Calotoxin,”Journal of the Chemical Society, Perkin Transactions 1: Organic and Bio-Organic Chemistry, (1972-1999) (1983), (12), pp. 2827-2835.
International Search Report, completed Feb. 23, 2004 and issued to a related foreign application.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

2″ oxo-voruscharin and derivatives thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 2″ oxo-voruscharin and derivatives thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 2″ oxo-voruscharin and derivatives thereof will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3964590

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.